Position in IONS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$60,705,983
-$21,967,210 QoQ
Shares Held
808,443
-22.6% QoQ
Ownership
0.489%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.23802420207733.ToString("F0")%
Shared 0.ToString("F0")%
None 2.761975797922674.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. IONS ranks #36 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in IONS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,705,983 | 808,443 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $82,673,193 | 1,045,041 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $68,494,084 | 1,046,990 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $60,423,551 | 1,529,323 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $57,039,460 | 1,890,602 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $67,039,573 | 1,917,608 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,725,271 | 167,880 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,276,345 | 152,672 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,445,925 | 171,763 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,081,193 | 159,739 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,945,781 | 109,034 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,808,608 | 92,825 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,607,808 | 100,946 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,098,759 | 161,471 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,711,739 | 61,310 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $6,299,581 | 170,167 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $7,452,484 | 201,201 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,890,913 | 193,589 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,454,514 | 132,812 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,188,095 | 155,129 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,306,627 | 29,062 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,088,972 | 72,320 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,168,633 | 108,928 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,874,829 | 48,759 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $4,307,348 | 91,103 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||